Core Insights - Experts at the 17th National Nutrition Science Conference reached a consensus on the clinical value of specific partially hydrolyzed whey protein formulas (pHF-W) in reducing allergy occurrence risk in infants [1] - Approximately 2%-3% of infants globally suffer from cow's milk protein allergy, with some cities in China reporting a 30.48% prevalence of atopic dermatitis in infants under one year old [1] - Traditional food allergy management has relied on strict dietary avoidance, but this approach has shown limitations in reducing severe allergic reactions [1] Group 1 - The shift in prevention strategies from passive avoidance to proactive early oral exposure is driven by a deeper understanding of food allergy mechanisms [1][2] - A study presented by Dr. Nicholas Hays revealed that feeding infants specific pHF-W for four months reduced the risk of atopic dermatitis by 35%, with significant improvements in skin barrier indicators for infants with a family history of allergies [2] - The ability to control the hydrolysis process allows for the reduction of sensitization while preserving immunomodulatory activity, simulating the tolerance-inducing mechanisms of breast milk [2] Group 2 - Early intervention in atopic dermatitis is crucial not only for skin management but also for blocking the initiation of allergic processes [3] - A dual intervention strategy targeting both skin and gut is essential for effective management of allergies [3]